readthroughSign in
CompanyNGNENasdaqNew York, NY

Neurogene Inc.

Neurogene develops gene therapies for neurological diseases using proprietary EXACT transgene regulation technology.

SCHEDULE 13G/ANov 16Latest SEC filing
Nov 17Latest story